These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

837 related articles for article (PubMed ID: 33569817)

  • 21. CRISPR/Cas9 and Genome Editing for Viral Disease-Is Resistance Futile?
    De Silva Feelixge HS; Stone D; Roychoudhury P; Aubert M; Jerome KR
    ACS Infect Dis; 2018 Jun; 4(6):871-880. PubMed ID: 29522311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Harnessing CRISPR technology for viral therapeutics and vaccines: from preclinical studies to clinical applications.
    Zahedipour F; Zahedipour F; Zamani P; Jaafari MR; Sahebkar A
    Virus Res; 2024 Mar; 341():199314. PubMed ID: 38211734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas Advancement in Molecular Diagnostics and Signal Readout Approaches.
    Ahmed MZ; Badani P; Reddy R; Mishra G
    J Mol Diagn; 2021 Nov; 23(11):1433-1442. PubMed ID: 34454111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish.
    Albadri S; Del Bene F; Revenu C
    Methods; 2017 May; 121-122():77-85. PubMed ID: 28300641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advancements of CRISPR technology in public health-related analysis.
    Gu X; Tang Q; Zhu Y; Sun C; Wu L; Ji H; Wang Q; Wu L; Qin Y
    Biosens Bioelectron; 2024 Oct; 261():116449. PubMed ID: 38850734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tools and targets: The dual role of plant viruses in CRISPR-Cas genome editing.
    Uranga M; Daròs JA
    Plant Genome; 2023 Jun; 16(2):e20220. PubMed ID: 35698891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field.
    He ZY; Men K; Qin Z; Yang Y; Xu T; Wei YQ
    Sci China Life Sci; 2017 May; 60(5):458-467. PubMed ID: 28527117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential of CRISPR/Cas system as emerging tools in the detection of viral hepatitis infection.
    Bahrulolum H; Tarrahimofrad H; Rouzbahani FN; Nooraei S; Sameh MM; Hajizade A; Ahmadian G
    Virol J; 2023 May; 20(1):91. PubMed ID: 37158910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-CRISPRs: Protein Inhibitors of CRISPR-Cas Systems.
    Davidson AR; Lu WT; Stanley SY; Wang J; Mejdani M; Trost CN; Hicks BT; Lee J; Sontheimer EJ
    Annu Rev Biochem; 2020 Jun; 89():309-332. PubMed ID: 32186918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRISPR based genome editing and removal of human viruses.
    Chen YC
    Prog Mol Biol Transl Sci; 2021; 179():93-116. PubMed ID: 33785179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRISPR Mediated Genome Engineering and its Application in Industry.
    Kaboli S; Babazada H
    Curr Issues Mol Biol; 2018; 26():81-92. PubMed ID: 28879858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR-Cas systems: ushering in the new genome editing era.
    Perez Rojo F; Nyman RKM; Johnson AAT; Navarro MP; Ryan MH; Erskine W; Kaur P
    Bioengineered; 2018; 9(1):214-221. PubMed ID: 29968520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRISPR-Cas system to discover host-virus interactions in Flaviviridae.
    Ramezannia Z; Shamekh A; Bannazadeh Baghi H
    Virol J; 2023 Oct; 20(1):247. PubMed ID: 37891676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diversification of the CRISPR Toolbox: Applications of CRISPR-Cas Systems Beyond Genome Editing.
    Balderston S; Clouse G; Ripoll JJ; Pratt GK; Gasiunas G; Bock JO; Bennett EP; Aran K
    CRISPR J; 2021 Jun; 4(3):400-415. PubMed ID: 34152221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted genome editing in human cells using CRISPR/Cas nucleases and truncated guide RNAs.
    Fu Y; Reyon D; Joung JK
    Methods Enzymol; 2014; 546():21-45. PubMed ID: 25398334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome Editing Strategies to Protect Livestock from Viral Infections.
    Söllner JH; Mettenleiter TC; Petersen B
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Advances in CRISPR-Cas-mediated genome editing system in plants].
    Wang C; Wang K
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1712-1722. PubMed ID: 29082719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells.
    Hendel A; Bak RO; Clark JT; Kennedy AB; Ryan DE; Roy S; Steinfeld I; Lunstad BD; Kaiser RJ; Wilkens AB; Bacchetta R; Tsalenko A; Dellinger D; Bruhn L; Porteus MH
    Nat Biotechnol; 2015 Sep; 33(9):985-989. PubMed ID: 26121415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of Infectious Viruses Using CRISPR-Cas12-Based Assay.
    Talwar CS; Park KH; Ahn WC; Kim YS; Kwon OS; Yong D; Kang T; Woo E
    Biosensors (Basel); 2021 Aug; 11(9):. PubMed ID: 34562891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of the CRISPR/Cas system for genome editing in microalgae.
    Zhang YT; Jiang JY; Shi TQ; Sun XM; Zhao QY; Huang H; Ren LJ
    Appl Microbiol Biotechnol; 2019 Apr; 103(8):3239-3248. PubMed ID: 30877356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.